Point72 Asset Management
TXG icon

Point72 Asset Management’s 10x Genomics TXG Stock Holding History

Point72 Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71M Buy
+1,852,776
New +$48.6M 0.08% 301
2024
Q4 		– Sell
-1,230,189
Closed -$27.8M – 2464
2024
Q3 		$27.8M Buy
+1,230,189
New +$25.4M 0.07% 323
2024
Q1 		– Sell
-497,282
Closed -$27.8M – 2635
2023
Q4 		$27.8M Sell
497,282
-850,137
-63% -$37M 0.07% 342
2023
Q3 		$55.6M Sell
1,347,419
-255,749
-16% -$13.3M 0.16% 149
2023
Q2 		$89.5M Buy
1,603,168
+1,066,837
+199% +$57.7M 0.27% 88
2023
Q1 		$29.9M Buy
+536,331
New +$25M 0.09% 261
2022
Q1 		– Sell
-171,462
Closed -$25.5M – 1399
2021
Q4 		$25.5M Buy
+171,462
New +$26.3M 0.1% 289
2021
Q2 		– Sell
-23,860
Closed -$4.32M – 1176
2021
Q1 		$4.32M Sell
23,860
-185,878
-89% -$32.1M 0.02% 600
2020
Q4 		$29.7M Buy
209,738
+112,661
+116% +$16.3M 0.14% 198
2020
Q3 		$12.1M Buy
97,077
+55,992
+136% +$5.88M 0.06% 371
2020
Q2 		$3.67M Sell
41,085
-213,960
-84% -$16.7M 0.02% 523
2020
Q1 		$15.9M Buy
+255,045
New +$19.9M 0.13% 233
2019
Q4 		– Sell
-400
Closed -$20K – 1261
2019
Q3 		$20K Buy
+400
New +$22.1K ﹤0.01% 1073

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management's TXG Position: Q2 2026 in Review

Point72 Asset Management opened a new position in 10x Genomics (TXG) in Q2 2026: 1,852,776 shares worth $71M. The stake represents 0.08% of the portfolio and ranks #301 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in TXG as recently as Q3 2024.

Point72 Asset Management first reported a position in TXG in Q3 2019 and has held it in 13 quarters since. The position peaked at $89.5M in Q2 2023. 391 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Point72 Asset Management held 1,852,776 shares of 10x Genomics worth $71M as of Q2 2026.
  • 10x Genomics was a new Point72 Asset Management position in Q2 2026.
  • 10x Genomics made up 0.08% of Point72 Asset Management's portfolio in Q2 2026, its #301 holding.
  • Point72 Asset Management first reported a position in 10x Genomics in Q3 2019 and has held it in 13 quarters since.
  • Point72 Asset Management's 10x Genomics position peaked at $89.5M in Q2 2023.
  • 391 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.